The Dual Perspectives of Modern Medicine

An image displaying a visual of differences in molecular structures between small molecule, large molecule and biologic drug structures from Edison Group

Most people don’t even think twice before reaching out for a pill, like ibuprofen for an instantaneous cure for a headache. However, not all medicines work that simply. Take a look at some of the most advanced cancer treatment drugs in the industry right now: most of these drugs cannot be swallowed, but are rather inserted into the body using injection or IV infusion instead. Looking into various treatments, the main difference in these drugs break off into two categories: small-molecule drugs and large molecule drugs (biologics). While one is built through precise chemical reactions, the other is produced using living cells. Although both types of drugs remain an essential to modern medicine, scientists have been prioritizing research in large molecule drugs, leading to further development in the treatment of larger health issues! The development of biologics can be seen as a great sign of innovation, as it is pushing towards treatment of more advanced and personal approaches, shaping the future of how illnesses and such diseases will be cured.

The Two Paths of Medicine 

The difference in structure plays a major role in how these drugs behave in the body. Small-molecule drugs are tiny, simple compounds, and this allows them to pass easily throughout cell membranes and survive in the digestive system. With these abilities, they are often taken as pills as the compounds are small enough to be able to pass through the digestive system while doing their part. In contrast, biologics are large and complex molecules, typically proteins, that would be broken down by acids in the stomach if they were to be swallowed. As a result, more higher level treatments must be administered through injections or IV infusions so that they can remain intact, effective and not be disintegrated by the acids in the stomach. 

How Size Shapes Functionality 

Beyond how these drugs are taken, these two types of drugs also differ in how they administer treatment towards different diseases. Small molecule drugs often have broader effects, interacting with multiple processes inside of the cell. A great example of small molecule drugs are our average over the counter drugs, such as Advil or Tylenol! They are typically taken as pills, or swallowed in some form. These drugs are chemically synthesized from a lab, and are made with smaller compounds. They pass throughout your body via the digestive system to help target germs in your body they want to fight off. Biologics, however, are designed to be highly specific, typically targeting a single protein or pathway inflicted with disease. Many healthcare research facilities tend to research or look into advancing biologics in our modern society. For example, companies such as Johnson and Johnson have been prioritizing in testing out new biologics made to help cure different conditions, as they have used this approach to develop new treatments. Johnson and Johnson has already developed a biologic for an uncommon and autoimmune condition called myasthenia gravis, which fights off the illness by killing off disease-causing proteins in a patient's body. Johnson and Johnson is still continuing to look into more large molecule cures, and so will the rest of the biotechnology industry as they progress. The ability of reaching such a high level of specificity to fight off these cells has made biologics crucial in treating complex conditions like cancer and other autoimmune conditions, 

The Cost of Complexity 

Despite these advances, biologics also come with challenges. With being made using living systems and the requirement of more complex manufacturing, they are significantly more expensive compared to small molecule drugs. Trends have been seen by researchers such as Favour Danladi Makurvet, where it is seen that biologics tend to be more expensive compared to small molecule drugs. THe precise process of how biologics are manufactured, as well as how it is hard to get approval by the FDA are both factors that contribute to high expenses in biologics. This range of possible pricing is an issue, as it can limit access for many patients to living a healthy life. Even though biologics are much more powerful treatments to certain conditions, small molecule drugs remain essential with their affordability, and widespread availability. 

Shaping the Future of Treatment

While both small-molecule drugs and biologics play important roles in modern medicine, the continued development of biologics is pushing treatment toward more advanced and personalized approaches. As scientists learn to harness the complexity of living systems, medicine will begin to move beyond simple, universal solutions, making it not only more powerful, but custom tailored to a patient’s needs.

References

Makurvet, F. D. (2021). Biologics vs. small molecules: Drug costs and patient access. Medicine nDrug Discovery, 9, 100075. https://doi.org/10.1016/j.medidd.2020.100075

(n.d.). 

https://www.edisongroup.com/thematic/the-a-b-t-of-biosimilars-explaining-contemporary-life-science-issues/

‌Sweeney, E. (2026, January 9). What are biologics?. JNJ.com.           https://www.jnj.com/innovation/what-are-biologic-medications